Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ragweed allergen refers to the proteins found in ragweed pollen that trigger allergic reactions in sensitized individuals. The major allergens are designated Amb a allergens, with Amb a 1 and Amb a 11 being among the most studied. Exposure leads to symptoms such as sneezing, runny nose, itchy eyes, and can exacerbate asthma. Diagnosis is typically performed via skin prick tests or specific IgE assays. Immunotherapy is a desensitization treatment aimed at reducing symptom severity.
Ragweed allergens bind IgE antibodies on mast cells/basophils, triggering release of histamine and other mediators, leading to hypersensitivity reactions.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ragweed Allergen.